Athenex, Inc. Announces Closing of Initial Public Offering and Full-Exercise of Over-Allotment Option
/
Date19 Jun 2017
BUFFALO, N.Y., June 19, 2017 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies... Read More →
ADOMANI Announces Initial Public Offering
/
Date15 Jun 2017
NEWPORT BEACH, Calif., June 15, 2017 (GLOBE NEWSWIRE) — ADOMANI Inc. (NASDAQ:ADOM), a provider of advanced zero emission vehicle solutions, announced today the completion of... Read More →
Nasdaq Welcomes Athenex, Inc. (Nasdaq: ATNX) to The Nasdaq Stock Market
/
Date14 Jun 2017
NEW YORK, June 14, 2017 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies... Read More →
Athenex, Inc. Announces Pricing of Initial Public Offering
/
Date14 Jun 2017
BUFFALO, N.Y., June 14, 2017 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies... Read More →
Uniti Group Inc. Announces Pricing of Offering of Common Stock
/
Date14 Jun 2017
LITTLE ROCK, Ark., April 19, 2017 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq:UNIT) announced today the pricing of its previously announced... Read More →
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
/
Date14 Jun 2017
NEWTON, Mass., April 24, 2017 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that it is commencing a registered underwritten... Read More →
Flexion Therapeutics Announces Proposed Convertible Senior Notes Offering
/
Date14 Jun 2017
BURLINGTON, Mass., April 25, 2017 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced its intention to offer, subject to market and other conditions, $125... Read More →
Crown Castle Announces Pricing of Senior Notes Offering
/
Date14 Jun 2017
HOUSTON, April 26, 2017 (GLOBE NEWSWIRE) — Crown Castle International Corp. (NYSE:CCI) (“Crown Castle”) announced today that it has priced its previously announced public offering... Read More →
UroGen Pharma Announces Pricing of Initial Public Offering
/
Date14 Jun 2017
RA’ANANA, Israel, May 03, 2017 (GLOBE NEWSWIRE) — UroGen Pharma Ltd., a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in... Read More →
Ovid Therapeutics Announces Pricing of Initial Public Offering
/
Date14 Jun 2017
NEW YORK, May 04, 2017 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc., a biopharmaceutical company, announced today that it has priced its initial public offering of... Read More →